Revitalist Executes on Vision to Become a Clinical Leader in Psychedelics


Ryan Allway

December 10th, 2021

Psychedelics, Top Story


Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) set out to build a nationwide network of psychedelic-assisted psychotherapy clinics in 2018. Since then, the company has grown its footprint to ten clinics across six states exceeding 60,650 sq. ft. of space and clinical capacity for more than 120 treatment rooms, with more to come.

The company believes that each treatment room could accommodate up to four visits per day at $490 per visit. Using these assumptions, the company’s 120+ treatment rooms could generate upwards of $60 million in annual revenue. 

These estimates aren’t merely guesses, either. The company recently reported $1.55 million in revenue and an estimated $1.17 million in gross income for the ten months leading up to October 31, 2021. These figures were double those from one year ago and come mainly from organic growth at its flagship clinic in Knoxville, TN.

Click here to receive an investor presentation and corporate updates

Beyond Physical Clinics

Revitalist hasn’t limited its focus to physical clinics. Next year, the company plans to launch its telemedicine platform targeting psychedelic therapies. As a result, the company could reach millions more people around the country beyond the reach of its network of clinics and provide better support to those who go into its clinics.

In November, the company also announced the acquisition of a 60% interest in Revitaland Meta Tech Inc. to create virtual clinics in the metaverse. The virtual world will enable patients and medical professionals to interact without being in the same physical space, improving accessibility without compromising the experience.

While the metaverse may seem far-fetched to many, Facebook’s move to rename its business “Meta” underscores just how central the concept is to tech giants. In addition, the COVID-19 pandemic and the rise of remote working are also pushing many consumers toward virtual meetings in the metaverse that could quickly become a ubiquitous environment.

Significant Potential

Revitalist’s significant progress in building out its physical and virtual clinic network and presence reflects the strength of its leadership team. In addition to its unparalleled medical expertise, the team includes veteran financiers and project managers that have a track record of growing $100+ million businesses.

CEO Katie Walker discusses the company’s growth strategy

Management hopes to build a network of nearly 50 clinics in 2022 before reaching more than 150 clinics by 2025. After establishing a footprint in the U.S., the company aims to expand to international locations in jurisdictions. These ambitions could yield a company generating upwards of $100 million in annual revenue at attractive gross margins.

Click here to receive an investor presentation and corporate updates

And, while these plans may seem ambitious on the surface, Stifel GMP research suggests that psychedelic-assisted psychotherapy (PAP) clinics have a total addressable market of over $10 billion in the U.S. alone. As a result, the company has significantly greater potential than its immediate plans over the long term to capitalize on the massive market.

Looking Ahead

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) represents a compelling opportunity to invest in the growth of psychedelic-assisted therapies—a field that many experts believe could revolutionize mental health treatments worldwide. As the company continues to expand, investors may want to take a closer look at the stock.

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading